Analyst Price Target is $31.67
▲ +51.01% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Avid Bioservices in the last 3 months. The average price target is $31.67, with a high forecast of $35.00 and a low forecast of $28.00. The average price target represents a 51.01% upside from the last price of $20.97.
Current Consensus is
The current consensus among 3 investment analysts is to buy stock in Avid Bioservices. This Buy consensus rating has held steady for over two years.
Avid Bioservices, Inc. engages in the commercial manufacturing. The firm focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.